23 de febrer 2019

Pharma returns

›
Measuring the return from pharmaceutical innovation 2018 Key findings for top 12 biopharma companies in the Deloitte study. R&D ret...
22 de febrer 2019

The bioethics of machine clinical decision making

›
Artificial intelligence (AI) in healthcare and research Regulation of predictive analytics in medicine This is what a brief note from Nuf...
21 de febrer 2019

Pharm niche busters

›
The Information Pharms Race and Competitive Dynamics of Precision Medicine: Insights from Game Theory Economic Dimensions of Personalized a...
16 de febrer 2019

Defining roles and skills for digital health

›
The Topol Review Preparing the healthcare workforce to deliver the digital future. The NHS asked Dr. Eric Topol about the new health work...
15 de febrer 2019

Who is worse off?

›
Health, priority to the worse off, and time The prioritisation of resource allocation towards the worse off is a well known rule. What doe...
08 de febrer 2019

The perfect storm of surveillance capitalism

›
THE AGE OF SURVEILLANCE CAPITALISM: The Fight for a Human Future at the New Frontier of Power THE DEFINITION 1. A new economic order t...
07 de febrer 2019

Medicine as a data science (5)

›
A guide to deep learning in healthcare Some months ago, Mckinsey released a guide to AI for executives . It says: Deep learning is a typ...
04 de febrer 2019

When the regulator doesn't care about the danger within us

›
A must see Netflix documentary: The bleeding edge . It explains how medical devices are introduced in the market without appropriate control...
02 de febrer 2019

Medicine as a data science (4)

›
The practical implementation of artificial intelligence technologies in medicine One of the critical issues for AI implementation in clini...
01 de febrer 2019

Medicine as a data science (3)

›
High-performance medicine: the convergence of human and artificial intelligence If you want to know the current state of artificial intell...
28 de gener 2019

In search for a fair price-setting in cancer drugs

›
Pricing of cancer medicines and its impacts We all know that new cancer drugs represent a challenge for the whole society. Expectations fr...
24 de gener 2019

Beyond nudges

›
Beyond Nudges — When Improving Health Calls for Greater Assertiveness From NEJM And a book:
21 de gener 2019

Barbarians at a drug firm

›
After Enron, Valeant Pharmaceuticals is one of the largest corruption scandals of Wall Street. If you want to know the details, you just hav...
20 de gener 2019

Incentives and behavior

›
THE MORAL ECONOMY WHY GOOD INCENTIVES ARE NO SUBSTITUTE FOR GOOD CITIZENS For those interested in pay for performance, the book by Samuel...